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Abstract
Interaction between different cell types is essential for multiple biological processes, including 
immunity, embryonic development, and neuronal signaling. While the dynamics of cell-cell 
interactions can be monitored in vivo by intravital microscopy19, this approach provides no 
information on the receptors and ligands involved, and does not allow isolation of interacting cells 
for downstream analysis. Here, we present a complementary approach that uses bacterial sortase 
labeling across immune synapses to identify receptor-ligand interactions between cells within 
living animals, generating a signal that can be readily detected by flow cytometry. We call this 
approach to labeling “kiss-and-run” interactions between immune cells Labeling Immune 
Partnerships by SorTagging Intercellular Contacts (LIPSTIC). Using LIPSTIC, we show that 
interactions between dendritic cells (DCs) and CD4+ T cells during T cell priming in vivo occur in 
two distinct modalities: an early, cognate stage when CD40-CD40L interactions occur specifically 
between T cells and antigen-loaded DCs, and a later, non-cognate stage when these interactions no 
longer require T cell receptor (TCR) engagement. Thus, LIPSTIC allows direct measurement of 
dynamic cell-cell interactions both in vitro and in vivo. Given its flexibility for use with different 
receptor ligand pairs and a range of detectable labels, we expect that this approach will be of use 
to any field of biology interested in quantifying intercellular communication.
LIPSTIC is based on proximity-dependent labeling across cell-cell interfaces using the 
Staphylococcus aureus transpeptidase Sortase A (SrtA). SrtA covalently transfers a substrate 
containing the sorting motif LPXTG to a nearby N-terminal oligoglycine20 (Extended data 
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Fig. 1). In LIPSTIC, a ligand and receptor of interest are genetically fused to either SrtA or 
to a tag consisting of five N-terminal glycine residues (G5) (Fig. 1a(i)). Addition of a SrtA 
substrate (e.g., an LPETG peptide linked at its N-terminus to a detectable label such as 
biotin or a fluorophore) leads to its loading onto SrtA on the donor cell via the formation of 
an acyl intermediate (Fig. 1a(ii)). Upon ligand-receptor interaction, SrtA catalyzes the 
transfer of the substrate onto the G5-tagged receptor (Fig. 1a(iii)). After cells separate, 
interaction history is revealed by the presence of the label on the surface of the G5-
expressing cell (Fig. 1a(iv)). To ensure that labeling occurs specifically as a readout of 
ligand-receptor interaction—rather than being driven by the affinity of SrtA toward G5—we 
employed an engineered SrtA variant with 13-fold lower affinity for G5 compared to wild-
type (WT) (KmGGG-COOH 1,830 ± 330 μM vs 140 ± 30 μM)21, orders of magnitude lower 
than most receptor-ligand interactions involved in immune function22–25.
To test this system, we transfected two populations of 293T cells separately with either G5-
CD40 or CD40L-SrtA, mixed the two populations in the presence of biotinylated SrtA 
substrate (biotin-LPETG) for 30 min, and then analyzed the cells by flow cytometry and 
Western blot. To determine specificity, G5-CD40 cells were also incubated with 293T cells 
transfected with SrtA fused to a CD40L variant carrying two point-mutations that strongly 
impair binding to CD4026,27 (CD40L*-SrtA, Extended data Fig. 2) or with untargeted SrtA 
anchored to the cell surface by the transmembrane domain of PDGFR (SrtA-PDGFR) (Fig. 
1b–c). Flow cytometric analysis showed that G5-CD40+ cells were biotinylated efficiently 
only when incubated with cells expressing WT CD40L-SrtA (Fig 1d). Western blotting 
confirmed that LIPSTIC labeling occurred via covalent modification of G5-CD40 (Fig. 1e). 
Specific intercellular labeling was also achieved using other ligand-receptor pairs involved 
in immune cell interaction and neuronal signaling, indicating that LIPSTIC can report on a 
variety of molecular interactions (Fig. 1f–h). To visualize the dynamics of LIPSTIC labeling 
in vitro, we imaged interactions between B cells transduced with G5-CD40 and CD4+ T 
cells transduced with CD40L-SrtA and pre-loaded with Alexa Fluor 647-LPETG. Substrate 
transfer between T and B cells was observed within minutes of interaction and at the 
interacting surface (Extended data Fig. 3 and Supplementary Video 1). We conclude that 
LIPSTIC is an efficient, specific and versatile method to label receptor-ligand interactions 
across cells in vitro, suitable for use with multiple receptor-ligand pairs and for detection by 
both flow cytometry and microscopy.
To determine whether LIPSTIC can function in vivo and at endogenous levels of receptor 
and ligand expression, we generated mice carrying Cd40G5 and Cd40lgSrtA alleles targeted 
to their endogenous loci (Extended data Fig. 4). Expression of G5-CD40 was made 
constitutive, while expression of CD40L-SrtA was designed to occur only upon Cre-
mediated excision of a translational stop cassette, so as to allow specification of the SrtA+ 
donor cell population. To measure LIPSTIC labeling during antigen-specific T cell-APC 
interactions, we crossed Cd40lgSrtA to CD4-Cre and to the OT-II TCR, specific for 
ovalbumin (OVA) peptide OVA323-339 (we refer to this strain as OT-II-SrtA). We co-cultured 
OT-II-SrtA CD4+ T cells for 6 h with Cd40G5/G5 splenic DCs pulsed either with OVA323-339 
or with a control LCMV-GP61-80 peptide, adding biotinylated substrate during the final 20 
min of culture (Fig. 2a). Efficient intercellular labeling occurred only when DCs were pulsed 
with cognate peptide, which correlated with induction of CD40L-SrtA expression on T cells. 
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DC labeling was strongly inhibited by addition of a blocking antibody to CD40L, 
confirming the requirement for CD40-CD40L interaction (Fig. 2b–c). LIPSTIC labeling was 
dose-responsive over a six-log range of OVA peptide concentrations (Fig. 2d–e). Triple co-
culture of OT-II-SrtA CD4+ T cells with two Cd40G5/G5 DC populations separately pulsed 
with either OVA323-339 or control LCMV-GP61-80 peptide showed that labeling was 
restricted to DCs loaded with the cognate antigen, also across a wide range of antigen doses 
(Fig. 2f–h). While labeling of cognate DCs increased with longer duration of substrate 
incubation, labeling of control DCs was negligible even when substrate was present for the 
full 6 h of co-culture (Extended data Fig. 5a–c). LIPSTIC was also capable of specifically 
identifying B cells productively engaged with antigen, as determined by triple co-culture of 
antigen-specific and polyclonal B cells with OT-II-SrtA CD4+ T cells (Extended data Fig. 
5d–g). Thus, LIPSTIC labeling in short-term in vitro priming experiments is dependent on 
receptor-ligand interaction, dose-responsive across a wide range of antigen concentrations, 
and specific to target cells displaying cognate antigen. Of note, although SrtA-CD40L was 
capable of stimulating B cell activation when expressed on 293T cells (Extended data Fig 
2c), B cell activation by CD40L-SrtA CD4+ T cells was impaired both in vitro and in vivo 
when compared to activation by T cells expressing WT CD40L, indicating that signaling by 
CD40L is partly compromised (Extended data Fig. 6a–b). This impairment was also seen in 
CD4-Cre− Cd40lgSrtA+/Y mice, where only a translated LoxP site is added to the C-terminus 
of CD40L (Extended data Fig. 6b), and therefore more likely represents a specific feature of 
the CD40L molecule than a general property of the SrtA fusion proteins. Nevertheless, 
experiments using DCs as APCs showed no measurable effect of the Cd40lgSrtA allele on T 
cell proliferation, indicating that the overall kinetics of T cell priming are not affected by 
CD40L insufficiency (Extended data Fig. 6c); we therefore used T cell-DC interactions to 
characterize LIPSTIC labeling in vivo.
To determine whether LIPSTIC can be used in vivo, we employed a well-established T cell 
priming model where OVA323-339-pulsed Cd40G5/G5 DCs are injected subcutaneously into 
the footpad of recipient mice, followed 18 h later by intravenous transfer of OT-II-SrtA 
CD4+ T cells28. We delivered LIPSTIC substrate to the popliteal lymph node (pLN) by 
footpad injection of a total of 300 nmol of biotin-LPETG over six injections between 10 and 
12 h after T cell transfer (Fig. 3a), when T cells are engaged in long-lived interactions with 
antigen-bearing DCs as determined by intravital imaging28. Flow cytometry of pLN cells 
showed efficient LIPSTIC labeling of transferred DCs, which was again dependent on T cell 
expression of CD40L-SrtA and sensitive to treatment with a CD40L blocking antibody (Fig. 
3b–c and Extended data Fig. 7a). Background labeling was negligible in all cell populations 
assayed (Extended data Fig. 7b). To further confirm the dependence of LIPSTIC labeling on 
CD40-CD40L interaction, we took advantage of the observation that, in the absence of a 
Cd40G5 allele, endogenous N-terminal glycines on the cell surface can function as low-
efficiency acceptors for the SrtA substrate29 (Extended data Fig. 7c–d). Such labeling was 
completely absent when Ag-loaded DCs were deficient in Cd40, again showing that CD40-
CD40L engagement is essential for labeling (Extended data Fig. 7e–f). Analysis of the 
kinetics of substrate clearance from labeled cells showed that a fraction of the label was still 
detectable at 4 and even 8 h after substrate injection (Extended data Fig. 7g–k).
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To measure interaction between CD4+ T cells and endogenous DCs upon immunization, we 
adoptively transferred OT-II-SrtA CD4+ T cells into Cd40G5/G5 hosts and performed in vivo 
LIPSTIC labeling at different times after footpad injection of 10 μg of OVA in alum adjuvant 
(Fig. 3d). LIPSTIC labeling was observed as early as 24 h after immunization on a small 
fraction of MHC-IIhi DCs, likely the pioneer APCs driving the initiation of the T cell 
response in the draining LN. The fraction of labeled DCs increased over time, peaking at 
10–15% of all DCs at 72 h post-immunization (Fig. 3e–f, Extended data Fig. 7l). Phenotypic 
analysis showed that labeling was restricted to MHC-IIhi DCs, mostly of the CD11b+ 
subtype. Labeling of XCR1+ DCs was a rare event, and was observed consistently—albeit at 
low levels—only at 72 h hours post immunization, in line with previous reports based on 
intravital imaging and histocytometry30 (Fig. 3g–h). We conclude that LIPSTIC can be used 
to follow the dynamics of CD40-CD40L contacts between T cells and DCs in vivo, with 
sufficient signal-to-noise to detect even rare and low-intensity interactions.
The finding that CD40-CD40L interaction between T cells and DCs peaks at 72 h post-
immunization (Fig. 3f), along with previous studies suggesting that CD40L may under 
certain circumstances engage its receptor in the absence of antigen presentation31–33, led us 
to hypothesize that LIPSTIC labeling later in the response may reflect non-cognate T cell-
DC interactions taking place during the motile “phase 3” of T cell priming by DCs28. To test 
this, we co-transferred into Cd40G5/G5 hosts two populations of DCs pulsed independently 
with either OVA323-339 (the cognate population) or LCMV-GP61-80 (the bystander 
population), followed by OT-II-SrtA CD4+ T cells (Fig. 4a). Whereas LIPSTIC labeling at 
12 h post-T cell transfer was detected only on cognate DCs, specificity was lost at 48 h, 
when both transferred and endogenous bystander DCs were also robustly labeled (Fig. 4b–c 
and Extended data Fig. 8a). To verify that bystander labeling was truly non-cognate—as 
opposed to resulting from transfer of antigenic peptide between DC populations—we 
performed identical co-transfer experiments but using H2−/− DCs as bystanders. LIPSTIC 
labeling of H2−/− DCs at late time points was indistinguishable from that of MHC-II-
sufficient bystanders under the same conditions (Fig. 4d). Non-cognate LIPSTIC labeling of 
bystander DCs at later time points was also observed upon OVA immunization of 
hematopoietic chimeras reconstituted with 80% Cd40G5/G5 and 20% Cd40G5/G5 H2−/− bone 
marrow (Extended data Fig. 8c–e), and during in vitro priming experiments analogous to 
those described in Fig. 2 (Extended data Fig. 9). Thus, CD40L-CD40 LIPSTIC labeling 
during late stages of T cell priming is not restricted to DCs presenting cognate antigen, in 
three distinct priming models.
To confirm non-cognate CD40-CD40L interactions in a system independent of LIPSTIC, we 
took advantage of the observation that CD40-dependent downregulation of surface CD40L 
on T cells can be used as a surrogate reporter for CD40-CD40L interaction in vivo32. We 
injected WT OVA323-339-pulsed DCs into either WT or Cd40−/− hosts, transferred OT-II 
CD4+ T cells one day later, then analyzed CD40L expression at 48 h after T cell transfer. 
While downregulation of CD40L could be observed in T cells transferred into WT hosts, this 
was not the case for T cells transferred into Cd40−/− hosts, despite the presence of CD40 on 
the transferred Ag-loaded DCs. CD40L downregulation was comparable in WT and in B 
cell-deficient (JHT) hosts, indicating that B cells do not contribute to CD40L downregulation 
(Fig. 4e–f). Thus, CD40L-CD40 interactions between T cells and with non-B cell APCs that 
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are not loaded with antigen can downregulate surface CD40L on the T cell, confirming the 
interactions between activated T cells and bystander DCs revealed by LIPTSIC. Moreover, 
similar downregulation of CD40L was observed in OT-II-SrtA T cells, indicating that the 
SrtA fusion does not prevent the downregulation of CD40L after it engages CD40 (Fig. 4e–
f).
Gene expression profiling of bystander biotin+ and biotin−host DCs revealed clear 
differences between these two populations. Principal component analysis detected a major 
component (accounting for 51% of total variance) by which biotin+ DCs were clearly 
separated from biotin− DCs, which in turn resembled bystander DCs from mice lacking 
CD40 (Fig. 4g), a conclusion also supported by hierarchical clustering (Extended data Fig. 
10c). Differential expression analysis identified 788 genes that differed significantly between 
conditions (fold change > 2 and FDR < 0.05), listed in Extended data Fig. 10d and 
Supplementary Table 1. We conclude that bystander interactions between T cells and DCs 
are associated with marked changes in gene expression, and CD40 ligation potentially plays 
a role in these alterations.
Finally, to determine whether the change in T cell-DC interaction patterns over time is due 
to a change in the properties of T cells or of DCs, we repeated the OVA323-339/LCMV-
GP61-80 DC co-transfer experiment but this time delaying T cell transfer to 62 h after DC 
injection, so that, at the time of labeling, DCs had been in the host for 70 h but T cells for 
only 12 h (Fig. 4h). This rescued the specificity of T cell interactions, in that only DCs 
pulsed with OVA323-339 peptide were labeled (Fig. 4i). Thus, newly primed T cells retain 
their specificity even when antigen-bearing DCs have been present for several days. We 
conclude that CD40-CD40L interactions between CD4+ T cells and DCs proceed in two 
stages. Initially, CD40L signals from arrested T cells are delivered specifically to antigen-
loaded DCs that are priming the response. This is followed by an antigen-independent stage 
in which motile, activated T cells are capable of interacting via CD40L even with DCs that 
are not presenting cognate antigen.
We introduce LIPSTIC, a novel system for labeling cell-cell interactions enzymatically both 
in vitro and in vivo. Although similar approaches have been proposed previously34–36, our 
system has a number of unique features: first, the use of a mutated version of SrtA with low 
affinity for the N-terminal oligoglycine makes SrtA less likely to be the driver of the cell-cell 
interaction and more likely to operate as a readout of interactions driven by high-affinity 
receptor-ligand pairs. Second, SrtA uses a peptide substrate that is easily synthesized and 
can be linked to a wide variety of detectable labels, including genetically-encoded 
fluorescent proteins or epitope tags20. Third, and most importantly, SrtA substrates can be 
readily administered to live animals, allowing us to detect and isolate cells based on their 
history of intercellular interactions in vivo. Given the importance of such interactions to 
immunology and other fields of biomedical science, we expect this technology will be 
widely useful to biologists in general, representing a useful complement to intravital 
microscopy.
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Methods
Plasmids
All constructs were cloned into the pMP71 vector37 which was modified to express a 
fluorescent reporter (eGFP or Tomato) followed by the porcine teschovirus-1 self-cleavable 
2A peptide38 and the protein of interest. The SrtA sequence, including a terminal FLAG-tag, 
was attached via a double 218 linker39 at the extracellular terminus of the modified receptor 
or ligand (C- or N-terminus, depending on protein topology). A five-glycine tag (G5) 
followed by a Myc tag was fused at the N-terminus of modified receptors or ligands. The 
sequences of all constructs used are reported in Supplementary Table 2.
Mice
C57BL6/J, CD45.1 (B6.SJL-Ptprca), Cd40−/− 40, Cd40lg−/− 41, H2−/− 42, CD4-Cre 
transgenic43 and ECFP-transgenic44 mice were purchased from The Jackson Laboratory 
(strain numbers 000664, 002014, 002928, 002770, 003584, 022071, and 004218, 
respectively). Cd40G5 and Cd40lgSrtA mice were generated and maintained in our 
laboratories. B1-8hi 45, JHT46, and OT-II TCR transgenic (Y chromosome)47 mice were 
originally provided by M. Nussenzweig (Rockefeller University, New York, USA). All mice 
were housed in specific pathogen-free facilities at the Whitehead Institute for Biomedical 
Research and The Rockefeller University in accordance with institutional guidelines and 
ethical regulations. All protocols were approved by the Massachusetts Institute of 
Technology Committee for Animal Care and the Rockefeller University Institutional Animal 
Care and Use Committee. Male and female 5-12 week-old mice were used in all 
experiments.
Generation of Cd40G5 and Cd40lgSrtA mice
The Cd40G5 mouse was generated by CRISPR/Cas9 gene targeting by cytoplasmic injection 
of Cas9 mRNA, chimeric sgRNA, and repair oligo into fertilized C57BL6 zygotes at the 
one-cell stage, as described48,49.
The sequence for the dsDNA template for chimeric Cd40G5 sgRNA transcription was as 
follows (protospacer sequence in capital letters): 
cgctgttaatacgactcactataggTCTGTTTTTAGGTCCATCTAgttttagagctagaaatagcaagttaaaataagg
ctagtccgttatcaacttgaaaaagtggcaccgagtcggtgctttt.
The Cd40G5 repair oligo was synthesized as an ssDNA ultramer, PAGE-purified (Integrated 
DNA Technologies). The repair oligo sequence was as follows (differences from original 
C57BL6 sequence are in lowercase): 
TGGCTGGCACAAATCACAGCACTGGCCATCGTGGAGGTACTGTTTGTCACTGCAC
GTAACggtacctcctccgcctccACACTGCCCTAGATGtACCTAAAAACAGAAGTGGACAGC
TGGAAGGGATCTTCCACCGGC
The Cd40lgSrtA mouse was generated using CRISPR/Cas9 gene-targeting by cytoplasmic 
injection of Cas9 mRNA, chimeric sgRNA, SCR7 (an NHEJ inhibitor, Excess Bioscience) 
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and repair plasmid into fertilized C57BL6 zygotes at the one-cell stage, as described in50, 
with the exception that the final concentration of SCR7 used was 100 μM.
The sequence of dsDNA template for chimeric Cd40lgSrtA sgRNA transcription was as 
follows (protospacer sequence in capital letters): 
cgctgttaatacgactcactataggAGAGTTGGCTTCTCATCTTTgttttagagctagaaatagcaagttaaaataag
gctagtccgttatcaacttgaaaaagtggcaccgagtcggtgctttt.
The sequence of the Cd40lgSrtA targeting construct is reported in Supplementary Table 2.
Cas9 mRNA was purchased from Sigma-Aldrich. Chimeric sgRNAs were in vitro-
transcribed from a synthetic dsDNA template (gBlock, Integrated DNA Technologies) using 
the MEGAshortscript™ T7 Transcription Kit (Thermo Fisher Scientific) and purified using 
Ampure XP beads (Beckman coulter).
Isolation of splenic DCs, CD4+ T cells and B cells
To isolate DCs, spleens were harvested, incubated 30 min at 37 °C in RPMI, 2% FBS, 20 
mM HEPES, 400 U/ml type IV collagenase (Worthington Biochemical Corporation) and 
disrupted to generate single cell suspensions. Red blood cells were lysed with ACK buffer 
(Lonza), and the resulting cell suspensions were filtered through a 70 μm mesh into PBS 
supplemented with 0.5% BSA and 2 mM EDTA (PBE). DCs were obtained by magnetic cell 
separation (MACS) using anti-CD11c beads (Miltenyi Biotec), as per manufacturer’s 
instructions. To isolate CD4+ T cells and B cells, spleens were processed as above, except 
for collagenase digestion, which was not performed. CD4+ T cells were isolated using CD4+ 
T cell isolation kit (Miltenyi Biotec) while B cells were obtained by negative selection using 
anti-CD43 beads (Miltenyi Biotec), as per manufacturer’s instructions. To isolate Igλ+ B 
cells form B1-8hi mice, B cells were stained with anti-Igκ PE antibody and subsequently 
purified by negative selection using a combination of anti-CD43 and anti-PE magnetic beads 
(Miltenyi Biotec).
Cell transfers, immunizations and treatments
For DC transfer experiments, splenic DCs isolated as described above were resuspended at 
107 cells/ml and pulsed with 10 μM OVA323-339 or LCMV-GP61-80 (both from Anaspec) in 
RPMI, 10% FBS, for 30 min at 37 °C. For cell labeling, CFSE was added to a final 
concentration of 2 μM during the last 5 min of incubation. Cells were then washed three 
times in RPMI, 10% FBS and resuspended at 2 × 107 cells/ml in PBS supplemented with 0.4 
μg/ml LPS. DCs were injected (5 × 105 cells in 25 μl) by subcutaneous injection into the 
hind footpad. For CD4+ T cell transfer experiments, CD4+ T cells isolated as described 
above were resuspended at 3 × 106 cells/ml in PBS and injected intravenously (3 × 105 cells 
in 100 μl/mouse).
For immunization experiments, mice were immunized by subcutaneous injection into the 
hind footpad of 10 μg OVA adsorbed in alum (Imject Alum, Thermo Scientific) at 2:1 
antigen:alum (v:v) ratio in 25 μl volume.
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For LIPSTIC in vivo labeling experiments, Biotin-LPETG (see below) was injected 
subcutaneously into the hind footpad (20 μl of 2.5 mM solution in PBS, equivalent to 50 
nmol). Mice were injected six times 20 min apart, and popliteal lymph nodes were harvested 
40 min after the last injection. Mice were briefly anesthetized with isoflurane at each 
injection.
For CD40L blockade experiments in vivo, mice were injected intravenously with 200 μg of 
CD40L blocking antibody (clone MR-1, BioXCell) at the indicated times.
Analysis of CD40L expression in vivo
C57BL/6J DCs were pulsed ex vivo with OVA323-339 and transferred subcutaneously (5 × 
105/footpad) to Cd40−/−, C57BL/6J, or JHT hosts. Eighteen hours later, 3 × 105 Cd40lg+/Y 
OT-II or CD40lgSrtA/Y CD4-Cre OT-II CD4+ T cells were transferred intravenously, and 
pLN were analyzed 48 hours post-T cell transfer.
Flow cytometry and cell sorting
Popliteal lymph nodes were harvested, incubated 30 min at 37 °C in RPMI, 2% FBS, 20 mM 
HEPES, 400 U/ml type 4 collagenase (Worthington Biochemical Corporation), disrupted 
using disposable micropestles (Axygen) and filtered through a 70 μm cell strainer. Single-
cell suspensions were washed with PBS, 0.5% BSA, 2mM EDTA (PBE), incubated at RT 
for 5 minutes with 1 μg/ml of anti-CD16/32 (2.4G2, BioXCell) and then stained for cell 
surface markers at 4 °C for 15 min in PBE using the reagents listed in Supplementary Table 
3. Cells were washed with PBS and stained with Zombie fixable viability dyes (Biolegend) 
at RT for 15 min and then fixed with Cytofix (BD Biosciences) before acquisition. In all in 
vivo experiments involving detection of Biotin-LPETG SrtA substrate, anti-biotin PE 
antibody (Miltenyi Biotec) was exclusively used due to its lower background compared to 
Streptavidin conjugates. To eliminate unspecific signal derived from PE binding by a 
fraction of the B cell population and thus reduce background, PE-Cy7 isotype control+ cells 
were excluded from analysis. In all in vivo experiments involving detection of CD40L, 
biotinylated anti-CD40L antibody (eBioscience) followed by anti-biotin PE antibody 
(Miltenyi Biotec) was used. Samples were acquired on Fortessa or LSR-II flow cytometers 
(BD Biosciences) and data were analyzed using FlowJo v.10.0.8 software.
RNA-sequencing of sorted DC populations
For the DC sorting experiment, Cd40G5/G5 DCs were pulsed with OVA323-339 and 
transferred subcutaneously (5 × 105/footpad) into Cd40G5/G5 recipients. Eighteen hours 
later, 3 × 105 CD40lgSrtA/Y CD4-Cre OT-II CD4+ T cells were transferred intravenously. 
Biotin-LPETG was administered subcutaneously (300 nmol/footpad) 46 hours post T cell 
transfer. 48 hours post T cell transfer popliteal lymph nodes were processed and stained for 
surface markers as above and endogenous biotin+ and biotin− MHC-IIhi CD11c+ CD11b+ 
XCR1– DCs were sorted. As controls, MHC-IIhi CD11c+ CD11b+ XCR1– DCs were also 
sorted from Cd40−/− mice treated as above, except that they received WT (instead of 
Cd40G5/G5) DCs and WT OT-II (instead of CD40lgSrtA/Y CD4-Cre OT-II) CD4+ T cells. 
Fresh cells were sorted (150 cells/sample) directly into plates containing TCL buffer 
(Qiagen) supplemented with 1% β-mercaptoethanol using a FACS Aria II (BD Biosciences). 
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RNA from sorted populations was isolated using Agencourt RNAClean XP beads (Beckman 
Coulter). Full-length cDNA and sequencing libraries were prepared using the Smart-seq2 
protocol as previously described51. Libraries were sequenced on a Nextseq500 (Illumina) to 
generate 38 base pair, paired-end reads.
Raw sequencing data were processed as described52. Briefly, short sequencing reads were 
aligned to the UCSC mm10 transcriptome using Bowtie2 (version 2.1.053). These 
alignments were used as input in RSEM (version 1.2.854) to quantify gene expression levels 
for all UCSC mm10 genes in all samples. Data were normalized and analyzed using the R 
software package DESeq2 (version 1.16.055). Genes with low read counts, defined as those 
that do not have normalized expression value greater than 100 in at least 3 samples, were 
filtered out, leaving 10,196 genes for the downstream analysis. The 500 genes with the 
largest variance were used for the principal component analysis and hierarchical clustering. 
For hierarchical clustering, the complete linkage clustering method was applied on pairwise 
distances, defined as 1- Pearson correlation coefficient. Paired differential expression 
analysis was performed for comparison between biotin+ and biotin− DC samples. The 
differentially expressed genes were compared against the MSigDB database to compute for 
enrichment using the hypergeometric test56.
Bone marrow chimeras
C57BL6/J recipient mice were lethally irradiated with two doses of 450 Rads given four 
hours apart. After irradiation, recipients were reconstituted by intravenous injection of 
hematopoietic cells harvested from femurs and tibiae of donor mice. Mice were used for 
experiments 8–12 weeks after irradiation.
Western blot
Cells were lysed in sample buffer supplemented with 100 mM dithiothreitol. Cell lysates 
were heated at 98 °C for 5 min and then cleared by centrifugation at 15,000 g for 10 min. 
Samples were separated by SDS-PAGE and transferred onto a nitrocellulose membrane. 
After blocking in 3% skim milk in PBS, membranes were incubated with 1–10 μg/ml 
primary antibody in 3% skim milk, PBS overnight at 4 °C. After several washes in PBS, 
0.1% Tween-20 (PBST), secondary antibodies coupled to HRP were applied in PBST for 1 h 
at RT when necessary. Blots were developed using Western lightning ECL (Perkin-Elmer) 
and BioMax MR films (Kodak).
SrtA substrates
Biotin-aminohexanoic acid-LPETGS (C-term amide, 95% purity) was purchased from 
LifeTein (custom synthesis) and stock solutions prepared in PBS at 20 mM.
SELPETGG (C-term amide, 95% purity) was purchased from LifeTein (custom synthesis) 
and conjugated with AlexaFluor647 succinimidyl ester dye (Thermo Fisher Scientific). 
Reacted peptide was purified by HPLC.
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Southern Blot
10 μg of genomic DNA purified from mouse tails was digested with XbaI and separated on 
0.8% agarose gel. Transfer and hybridization was performed as described57. Blots were 
developed using Storage Phosphor Screens (GE Healthcare) and Typhoon Imaging System 
(GE Healthcare). The sequence of the probe used is as follows: 
GGTCAACCTGGGTTCCATAAAATCTTGTCTTCCCCCAAAAGGGGATAAATTCAGT
AGACAGAGGCAGGTAGATCTCTGTGAGTCCCAAGCTAGCCTAGTCTGCATAACAA
GTTGTAGGCCAGCTTCTGTTTTCTTTTCTGTCTCAAAAAAGAAAGCAGAAGTGTA
AGTGGGTAATGTATTTATTAAACTGAAAAGAATCTGGTCCTTTTTTTCTCATTCAAA
TGGTTCAAAAGTGAAAACATCACAAAACAAACATCCTTTATAGAGAATTTGGGGT
GCAATGTATCAG.
LIPSTIC in vitro
293T cells were transfected using calcium phosphate transfection kit (Thermo Fisher 
Scientific) with the indicated expression vectors. Forty hours post transfection, cells were 
detached using non-enzymatic cell dissociation solution (Thermo Fisher Scientific), washed, 
and resuspended at 107 cell/ml in PBS. Cell populations transfected with G5- or SrtA-fusion 
constructs were mixed at 1:1 ratio (106 cells of each population) in a 1.5 ml conical tube, to 
which biotin-LPETG was added to a final concentration of 100 μM. Cells were incubated at 
RT for 30 min and washed three times with PBE to remove excess biotin-LPETG prior to 
FACS staining or Western blot.
Imaging LIPSTIC in vitro
B cells and CD4+ T cells were isolated from mouse spleens as described above; B cells were 
activated with 25 μg/ml LPS and 10 ng/ml IL-4 whereas CD4+ T cells were activated with 
CD3/CD28 dynabeads and rat T-STIM conditioned media (both from Thermo Fisher 
Scientific). Twenty-four hours later, cells were transduced with retroviral vectors. 
Transduced cells were sorted two days post transduction based on expression of the 
fluorescent reporter present in the retroviral vector. CD4+ T cells were incubated with 
AlexaFluor647-SELPETGG for 30 min at 37 °C, washed three times, and seeded together 
with B cells on 8-well Lab-tek chamber slides (Sigma-Aldrich) previously coated with 12.5 
ug/ml ICAM (2 × 105 cells/well, 1:1 ratio). Cells were immediately imaged using an Andor 
widefield microscope equipped with a live cell incubation system. Images were acquired 
with 40X objective every 45 s for 90 min using Metamorph software.
LIPSTIC ex vivo
DCs, B cells and CD4+ T cells were isolated from mouse spleens as described above. 
Isolated DCs were pulsed for 2.5 hours at 37 °C with the indicated concentration of 
OVA323-339 or LCMV-GP61-80 peptides in RPMI 10% FBS supplemented with LPS 10 
μg/ml, washed three times, and then seeded into U-bottom 96 well-plates together with 
purified CD4+ T cells (2 × 105 cells/well, 1:1 ratio). Cells were co-cultured for 6 (Fig. 2 and 
Extended data Fig. 5) or 24 hours (Extended data Fig. 9), and biotin-LPETG was added at 
the indicated time of co-culture at a final concentration of 10 μM in complete medium. 
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Blocking antibodies were added at the beginning of co-culture (Fig. 2) or at the indicated 
times (Extended data Fig. 9) and used at a final concentration of 150 μg/ml.
Purified B cells (either polyclonal or Igλ+ B1-8hi) were cooled for 30 min on ice and then 
incubated for 45 min on ice with the indicated concentrations of NP-OVA (Biosearch 
Technologies). Cells were then washed twice and seeded into U-bottom 96 well-plates 
together with CD4+ T cells (2 × 105 cells/well, 1:1 ratio) previously activated with CD3/
CD28 dynabeads (Thermo Fisher) for 24 h. Cells were co-cultured for 18 h, and biotin-
LPETG was added during the last 30 min of co-culture at a final concentration of 100 μM in 
complete medium.
In all experiments, cells were washed three times with PBE before FACS staining to remove 
excess biotin-LPETG substrate.
Statistical analysis
Statistical tests were conducted using Prism (GraphPad) software. Gaussian distribution was 
confirmed by the Shapiro–Wilk normality test. Unpaired, two-tailed Student’s t-tests and 
one-way ANOVA with Tukey’s post hoc tests to further examine pairwise differences were 
used.
Data availability
RNA-sequencing are deposited in GEO under accession number GSE107643. All other data 
are included within the article or are available upon request.
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Extended Data
Extended Data Figure 1. Schematic representation of the SrtA reaction
SrtA enzyme recognizes the short amino acid sequence LPXTG (where X is any amino 
acid). Upon binding, SrtA forms a covalent acyl intermediate between the threonine of the 
substrate and the cysteine present in its catalytic pocket. The reaction proceeds with the 
formation of an amide bond between substrate threonine and an N-terminal glycine. 
Affinities displayed refer to engineered SrtA variants carrying mutations P94S, D160N, and 
K196T.
Extended Data Figure 2. Two point mutations in mouse CD40L coding sequence impair binding 
to CD40
a, Sequence alignment of human and mouse CD40L proteins. Due to the lack of 
crystallographic data describing mouse CD40-CD40L complex, we identified residues 
potentially engaged in CD40 binding based on information available for the human CD40-
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CD40L complex. Residues in human CD40L sequences engaged in interaction with CD40 
based on crystallographic data are highlighted in blue. Among these, residues for which a 
charge reversal mutation was shown to affect CD40 binding are boxed. Filled boxes identify 
the residues in mouse CD40L for which a charge reversal mutation was performed (K142E 
and R202E). Mutations at equivalent locations in the human CD40L coding sequence 
(K143, R203) have also been detected in hyper-IgM patients. CD40L carrying both 
mutations (K142E and R202E) is identified as CD40L*. b, Binding of CD40 to CD40L-
SrtA and CD40L*-SrtA. 293T cells were transfected with CD40L-SrtA or CD40L*-SrtA, 
incubated with CD40-Fc protein and analyzed by flow cytometry. Histogram plots show 
severe impairment of CD40 binding to CD40L*-SrtA. c, B cell activation by CD40L-SrtA 
and CD40L*-SrtA. Primary murine B cells were cultured on a monolayer of 293T cells 
expressing CD40L-SrtA or CD40L*-SrtA. CD86 surface expression was analyzed by flow 
cytometry eighteen hours later. Histogram plots show reduced upregulation of CD86 in B 
cells stimulated with CD40L*-SrtA. Data representative of two independent experiments.
Extended Data Figure 3. Imaging of LIPSTIC labeling
a, Experimental set up for live imaging of LIPSTIC labeling. Cd40−/− B cells and Cd40lg−/Y 
CD4+ T cells were transduced with G5-CD40 (Tomato reporter) or CD40L-SrtA (GFP 
reporter), respectively. CD40L-SrtA+ T cells were loaded with AlexaFluor647-SELPETGG, 
mixed with G5-CD40+ B cells on intercellular adhesion molecule (ICAM)-coated chambers 
to allow interactions, and immediately imaged. b, Time series showing transfer of 
AlexaFluor647-SELPETGG (white) from CD40L-SrtA+ T cells (green) to G5-CD40+ B 
cells (red) upon interaction. Data are representative of two independent experiments.
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Extended Data Figure 4. Generation of Cd40G5 and Cd40lgSrtA gene-targeted mice
a, b, Schematic representation and CRISPR/Cas9 genome editing strategy for the Cd40G5 
(a) and Cd40lgSrtA (b) alleles. c, Restriction fragment length polymorphism (RFLP) analysis 
of Cd40G5/+ mice. c, PCR products generated using primers surrunding the G5 insertion site 
were digetsted with KpnI and analyzed by electrophoresis on an agarose gel. Data are 
representative of at least two experiments. d, Southern blot analysis of Cd40lgSrtA/+ mouse. 
Genomic DNA was extracted, digested with XbaI, and transferred onto a nitrocellulose 
membrane after electrophoresis on an agarose gel. Genomic DNA fragments were detected 
using a probe annealing between exons 4 and 5.
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Extended Data Figure 5. LIPSTIC labeling ex vivo
a, Experimental setup followed in b–c to assess the influence of substrate incubation length 
on intercellular labeling between primary DCs and CD4+ T cells. Cd40G5/G5 DC 
populations were separately pulsed with 1 μM of OVA323-339 or LCMV-GP61-80, mixed, and 
co-cultured for 6 hours with Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells. Biotin-LPETG was 
added during the final 1, 5, 10, 20, 180 min of co-culture or for the entire co-culture time 
(360 min) at a final concentration of 10 μM, and cells were analyzed by flow cytometry. b, 
Flow cytometric analysis of co-cultured DCs incubated with biotin-LPETG for the indicated 
times. c, Percentage of biotin+ DCs gated as in b. d, Experimental set-up followed in e–g to 
probe intercellular labeling ex vivo between primary B cells and CD4+ T cells. Two 
populations of Cd40G5/G5 B cells that either carried a WT polyclonal B cell receptor (BCR) 
repertoire or expressed the B1-8hi Ig heavy chain, which when paired to an Igλ light chain 
confers specificity towards the hapten 4-Hydroxy-3-nitrophenylacetyl (NP), were mixed and 
pulsed with the indicated concentrations of NP-OVA. Cells were then co-cultured for 
eighteen hours with Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells. Biotin-LPETG was added 
during the last thirty min of co-culture at a final concentration of 100 μM, and cells analyzed 
by flow cytometry. e, Flow cytometric analysis of B cells pulsed with 1 nM of NP-OVA 
showing preferential biotin labeling of B1-8hi λ+ B cells. f, Percentage of biotin+ B cells 
among polyclonal and B1-8hi λ+ populations at the indicated NP-OVA concentrations. g, 
Flow cytometric analysis of B cells pulsed with 1 nM of NP-OVA showing positive 
correlation between biotin labeling and expression of the activation marker CD69. Data 
representative of three independent experiments.
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Extended Data Figure 6. Characterization of Cd40lgSrtA/Y T cells
a, Upregulation of CD86 on B cells by CD40L-SrtA. B1-8hi λ+ B cells were pulsed with the 
indicated concentrations of NP-OVA and co-cultured with Cd40lgSrtA/Y CD4-Cre OT-II or 
WT OT-II CD4+ T cells for 18 hours. Cells were analyzed by flow cytometry. Graph shows 
percentage of CD86+ B cells when co-cultured with Cd40lgSrtA/Y CD4-Cre OT-II or Wt OT-
II T cells in the presence of varying concentrations of NP-OVA. b, Germinal center 
formation in Cd40lgSrtA/Y and Cd40lgSrtA/Y CD4-Cre mice. C57BL/6J, Cd40lg+/Y and 
Cd40lgSrtA/Y CD4-Cre mice were immunized subcutaneously with 20 μg of NP-OVA in 
alum at the base of the tail. Inguinal LNs were analyzed by flow cytometry 12 days post-
immunization. Dot plots show the absence of germinal center formation in both 
Cd40lgSrtA/Y and Cd40lgSrtA/Y CD4-Cre mice, suggesting impaired ability of Cd40lgSrtA/Y 
T cells to activate B cells. A similar phenotype is observed regardless of the presence of Cre 
recombination, likely due to the addition of a translated LoxP site to the C-terminus of the 
CD40L protein. c, In vivo expansion of Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells. 5 × 105 
Cd40G5/G5 DCs pulsed ex vivo with OVA323-339 were injected subcutaneously into the hind 
footpad of C57BL/6J recipients. Eighteen hours later, 3 × 105 CFSE labeled CD40lgSrtA/Y 
CD4-Cre OT-II (or Cd40lg+/Y OT-II as control) CD4+ T cells were transferred intravenously. 
Popliteal LNs were analyzed by flow cytometry 72 hours after T cell transfer. Histogram 
plots show comparable expansion of both transferred T cell populations, as indicated by 
CFSE dilution. Data representative of two independent experiments.
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Extended Data Figure 7. Characterization of LIPSTIC labeling in vivo
a, CD40L-SrtA expression in Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells in vivo upon DC 
transfer. Mice were treated as in Fig. 3a. Flow cytometric analysis of pLN cells shows 
transferred Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells expressing CD40L-SrtA as revealed 
by the detection of biotin staining (formation of an acyl intermediate between SrtA and 
biotin-LPETG). CD40L-SrtA expression requires DC presentation of cognate antigen 
(OVA323-339), is not affected by αCD40L blocking antibody treatment, and positively 
correlates with the activation marker CD69. b, Detection background in major leukocyte 
populations. Cd40G5/G5 CD45.1/2 DCs were pulsed with OVA323-339 and transferred 
subcutaneously (5 × 105/footpad) into Cd40G5/G5 recipients. Eighteen hours later, 3 × 105 
CD40lgSrtA/Y CD45.1/1 CD4-Cre OT-II (or Cd40lg+/Y CD45.1/1 OT-II lacking Cre 
expression as control) CD4+ T cells were transferred intravenously. Biotin-LPETG (or PBS 
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as control) was administered subcutaneously (300 nmol/footpad) 10 to 12 hours after T cell 
transfer and pLNs were analyzed by flow cytometry. Plots show biotin staining among B 
cells, CD4+ T cells and DCs. c, Efficiency of labeling of Cd40G5/G5 and Cd40+/+ DCs upon 
T cell-DC interaction in vivo. Cd40G5/G5 and Cd40+/+ DCs were pulsed ex vivo with 
OVA323-339, mixed, and injected subcutaneously into C57BL/6J recipients (5 × 105/footpad). 
Eighteen hours later, 3 × 105 CD40lgSrtA/Y CD4-Cre OT-II CD4+ T cells were transferred 
intravenously. Biotin-LPETG was administered subcutaneously (300 nmol/footpad) 10 to 12 
hours after T cell transfer. Dot plots show flow cytometric analysis of transferred Cd40G5/G5 
and Cd40+/+ DCs. d, Percentage (left panel) and MFI (right panel) of biotin+ DCs (gated as 
in c) among transferred DC populations. Labeling of Cd40+/+ DCs likely reflects biotin-
LPETG transfer onto endogenous N-terminal glyclines. Each symbol represents one mouse; 
bar indicates mean. e, Labeling of endogenous N-terminal glycines requires CD40L-CD40-
interaction. Experimental set-up as in c, except that a mixture of C57BL/6J and Cd40−/− 
DCs was transferred. Dot plots show flow cytometric analysis of transferred Cd40+/+ and 
Cd40−/− DCs. f, Percentage of biotin+ DCs gated as in e among transferred DC populations. 
Each symbol represents one mouse; bar indicates mean. g, Graphic representation of the 
experimental protocol followed in h–k to determine the clearance of surface biotin labeling. 
Cd40G5/G5 DCs were pulsed with OVA323-339 and transferred subcutaneously (5 × 105/
footpad) into C57BL/6J recipients. Eighteen hours later, 3 × 105 CD40lgSrtA/Y CD4-Cre OT-
II CD4+ T cells were transferred intravenously, biotin-LPETG was administered 
subcutaneously (300 nmol/footpad) 10 to 12 hours after T cell transfer. pLN were harvested 
and analyzed by flow cytometry 0, 4, 8 or 24 hours after the final biotin-LPETG injection. h, 
Flow cytometric analysis of pLN cells showing biotin labeling of transferred Cd40G5/G5 
DCs at the indicated hours after biotin-LPETG administration. i, Percentage (left panel) and 
MFI (right panel) of biotin+ DCs among the transferred Cd40G5/G5 DCs gated as in h. Each 
symbol represents one mouse; bar indicates mean. j, Flow cytometric analysis of pLN cells 
showing biotin labeling of transferred Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T at the indicated 
time points after biotin-LPETG administration. k, Percentage (left panel) and MFI (right 
panel) of biotin+ cells among the transferred Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells 
gated as in h. Each symbol represents one mouse; bar indicates mean. l, CD40L-SrtA 
expression in Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells in vivo upon immunization. Mice 
were treated as in Fig. 3d. Flow cytometric analysis of pLN cells showing transferred 
Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells in mice left untreated (left) or treated with 
αCD40L blocking antibody 4 hours prior to pLN harvesting (right). Data representative of 
two independent experiments.
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Extended Data Figure 8. CD40-CD40L interaction between CD4+ T cells and DCs in vivo can 
occur in an antigen independent manner
a, MFI of biotin+ DCs 48 hours after T cell transfer in mice treated as in Fig. 4a. Each 
symbol represents one mouse; bar indicates mean. Data pooled from two independent 
experiments. b, MFI of biotin+ DCs 48 hours after T cell transfer in mice treated as in Fig. 
4d. Each symbol represents one mouse; bar indicates mean. c, Graphic representation of the 
experimental protocol followed in d–e. C57BL/6J mice were lethally irradiated and 
reconstituted with a mixture of Cd40G5/G5 (80%) and Cd40G5/G5 H2−/− (20%) bone marrow. 
After reconstitution, bone marrow chimeras received 3 × 105 Cd40lgSrtA/Y CD4-Cre OT-II 
CD4+ T cells intravenously and were immunized the following day with 10 μg of OVA in 
alum in the hind footpad. pLN were analyzed 24, 48, 72 and 96 hours post-immunization. 
Biotin-LPETG was administered subcutaneously (300 nmol/footpad) during the last two 
hours prior to analysis. d, Flow cytometric analysis of pLN cells showing biotin labeling of 
endogenous Cd40G5/G5 and Cd40G5/G5 H2−/− DCs at 24 or 72 hours post-immunization. e, 
Percentage of biotin+ DCs among Cd40G5/G5 and Cd40G5/G5 H2−/− DCs gated as in d. Each 
symbol represents one mouse; bar indicates mean. Data pooled from two independent 
experiments.
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Extended Data Figure 9. CD40-CD40L interaction between CD4+ T cells and DCs ex vivo can 
occur in an antigen independent manner
a, Experimental set-up followed in b–e. Two Cd40G5/G5 DCs populations were individually 
pulsed with the indicated concentrations of either OVA323-339 or LCMV-GP61-80, mixed, and 
co-cultured for 24 hours with Cd40lgSrtA/Y CD4-Cre OT-II CD4+ T cells. Biotin-LPETG 
was added during the last twenty min of co-culture at a final concentration of 10 μM, and 
cells analyzed by flow cytometry. Where indicated, αCD40L or αMHC-II blocking 
antibodies were added at a final concentration of 150 μg/ml either at the beginning of co-
culture (t=0) or 2 hours before analysis (t=22). b, Flow cytometric analysis of DCs pulsed 
with 1 μM peptides showing biotin labeling. c–e, Percentage of biotin+ DCs gated as in b. 
Data representative of three independent experiments.
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Extended Data Figure 10. RNA sequencing analysis of sorted biotin+ DCs
a, Graphic representation of the protocol for DC sorting. 5 × 105 Cd40G5/G5 CFSE-labeled 
DCs pulsed ex vivo with OVA323-339 were transferred subcutaneously into the hind footpad 
of Cd40G5/G5 recipients. Eighteen hours later, 3 × 105 CD40lgSrtA/Y CD4-Cre OT-II CD4+ T 
cells were transferred intravenously. Biotin-LPETG was administered subcutaneously (300 
nmol/footpad) during the last two hours before analysis. pLN were harvested 48 hours post-
T cell transfer and DC populations were sorted by flow cytometry and later processed for 
RNA sequencing analysis. As controls, DCs were also sorted from Cd40−/− mice, which 
were treated as above except that they received WT (instead of Cd40G5/G5) DCs and WT 
OT-II (instead of CD40lgSrtA/Y CD4-Cre OT-II) CD4+ T cells. b, Gating strategy for sorting. 
Endogenous DCs were first identified as B220− CD3− NK1.1− MHC-II+ CD11c+ CFSE−. 
Sorting was restricted to CD11b+ XCR1− DCs showing an activated phenotype (MHC-IIhi), 
which represent the major population involved in bystander interactions. Biotin+ and biotin− 
DCs were gated as shown. c, Hierarchical clustering of transcriptomic profiles. Color 
scheme is based upon Pearson correlation. Data are derived from a single experiment, n=3. 
d, Volcano plots showing differential gene expression between biotin+ and biotin− DCs. All 
genes used for the differential expression analysis are shown; differentially expressed genes 
(log2 fold change > 1 and FDR < 0.05, see Methods section) are colored red. Data are 
derived from a single experiment, n=3.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Using LIPSTIC to track ligand-receptor interactions
a, Schematic representation of the LIPSTIC approach. b, Constructs used in c–e. All 
constructs express a bicistronic gene encoding for a fluorescent reporter protein. c, 
Experimental setup to probe intercellular labeling in transfected 293T cells. d, Gating 
strategy and histograms showing biotin staining in SrtA+ cells (left column, indicating the 
formation of the acyl intermediate) and G5-CD40+ cells (right column, indicating 
intercellular transfer). Dashed line histograms represent untransfected cells. e, Western blot 
showing expression of G5-CD40 (anti-Myc), SrtA fusion constructs (anti-FLAG), and 
intercellular labeling (Streptavidin). αTubulin, loading control. f, Constructs used in g–h. g, 
h, Biotin staining in SrtA+ cells (acyl intermediate) and G5+ cells (intercellular transfer). 
Dashed line histograms represent untransfected cells. Solid line histograms and gray 
histograms represent G5+ cells mixed with untransfected and SrtA-PDGFR donor cells, 
respectively. Data are representative of three independent experiments.
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Figure 2. LIPSTIC labeling of CD40-CD40L interactions ex vivo
a, Experimental setup for b–e. b, Flow cytometry for biotin labeling on DCs pulsed with 1 
μM of the indicated peptide (intercellular transfer). c, Flow cytometry for biotin labeling of 
CD4+ T cells (acyl intermediate). d, e Percentage (left panel) and median fluorescence 
intensity (MFI, right panel) of biotin+ DCs and CD4+ T cells, respectively. f, Experimental 
setup for g–h; timeline as in a. g, Flow cytometric analysis of DCs pulsed with 0.1 or 10 μM 
of the indicated peptides showing biotin labeling (intercellular transfer). h, Percentage (left 
panel) and MFI (right panel) of biotin+ DCs gated as in g. All data are representative of three 
independent experiments.
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Figure 3. LIPSTIC enables monitoring of CD40-CD40L interactions between T cells and DCs in 
vivo
a, Experimental setup for b–c. b, Flow cytometric analysis of pLN cells showing biotin 
labeling of transferred Cd40G5/G5 DCs. c, Percentage of biotin+ DCs among the transferred 
DC populations gated as in b. Each symbol represents one mouse; bar indicates mean. Data 
pooled from two independent experiments. d, Experimental setup for e–h. e, Flow 
cytometric analysis of pLN cells showing biotin labeling of endogenous DCs at different 
times after immunization in mice left untreated (top row) or treated with α-CD40L blocking 
antibody (bottom row). f, Percentage of biotin+ DCs among endogenous DCs gated as in e. 
Each symbol represents one mouse; bar indicates mean. Data are pooled from two 
independent experiments. g, Flow cytometric analysis of pLN cells showing biotin labeling 
among endogenous CD11b+ or XCR1+ DCs at 24 or 72 hours post-immunization. h, 
Percentage of biotin+ DCs among endogenous CD11b+ or XCR1+ DCs gated as in g. Each 
symbol represents one mouse; bar indicates mean. Data pooled from two independent 
experiments.
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Figure 4. Different modalities of CD40-CD40L interaction between CD4+ T cells and DCs in vivo
a, Experimental setup for b–c. b–c, Flow cytometric analysis of pLN cells showing biotin 
labeling of endogenous and transferred DCs 12 (b) or 48 (c) hours post-T cell transfer. d, 
Flow cytometry of pLN cells showing biotin labeling of transferred DCs 48 hours post-T 
cell transfer. Experimental set up as in a, except that bystander DCs are H2−/−. e, CD40L 
expression in activated CD4+ T cells. Histogram plots show CD40L surface staining in 
Cd40lg+/Y OT-II (left panel) or Cd40lgSrtA/Y CD4-Cre OT-II (right panel) CD69+ CD4+ T 
cells. Data representative of two independent experiments. f, Graph shows percentage of 
CD69+ CD4+ T cells positive for CD40L. One-way ANOVA with Tukey’s post-hoc test and 
unpaired, two-tailed Student’s t-test were used for statistical analysis. g, Principal 
component analysis of transcriptomic profiles of endogenous biotin+ and biotin− MHC-IIhi 
CD11c+ CD11b+ XCR1– DCs sorted 48 hours post-T cell transfer from mice treated as in a. 
Each symbol represents one sample derived from one mouse in a single experiment. h, 
Experimental setup for i. i, Flow cytometry of pLN cells showing biotin labeling of 
endogenous and transferred Cd40G5/G5 DCs 12 hours post-T cell transfer. Graph represents 
percentage of biotin+ DCs gated as shown among different DC populations. b–d, f, i, Each 
symbol represents one mouse; bar indicates mean; data pooled from two independent 
experiments.
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